User profiles for Tom Palmer

Tom Palmer

- Verified email at bristol.ac.uk - Cited by 11722

Tom Palmer

- Verified email at ucl.ac.uk - Cited by 768

Mendelian randomization

…, H Kang, J Morrison, MR Munafò, T Palmer… - Nature Reviews …, 2022 - nature.com
Mendelian randomization (MR) is a term that applies to the use of genetic variation to
address causal questions about how modifiable exposures influence different outcomes. The …

[HTML][HTML] Collider bias undermines our understanding of COVID-19 disease risk and severity

…, L Pike, GC Sharp, J Sterne, TM Palmer… - Nature …, 2020 - nature.com
Numerous observational studies have attempted to identify risk factors for infection with
SARS-CoV-2 and COVID-19 disease outcomes. Studies have used datasets sampled from …

Mendelian randomization of blood lipids for coronary heart disease

MV Holmes, FW Asselbergs, TM Palmer… - European heart …, 2015 - academic.oup.com
Aims To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and
triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian …

The MRC IEU OpenGWAS data infrastructure

…, Y Liu, P Matthews, J Hallett, P Bates, T Palmer… - BioRxiv, 2020 - biorxiv.org
Data generated by genome-wide association studies (GWAS) are growing fast with the
linkage of biobank samples to health records, and expanding capture of high-dimensional …

Using multiple genetic variants as instrumental variables for modifiable risk factors

TM Palmer, DA Lawlor, RM Harbord… - … methods in medical …, 2012 - journals.sagepub.com
Mendelian randomisation analyses use genetic variants as instrumental variables (IVs) to
estimate causal effects of modifiable risk factors on disease outcomes. Genetic variants …

[HTML][HTML] Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian …

TG Richardson, E Sanderson, TM Palmer… - PLoS …, 2020 - journals.plos.org
Background Circulating lipoprotein lipids cause coronary heart disease (CHD). However,
the precise way in which one or more lipoprotein lipid-related entities account for this …

Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals

…, PK Joshi, L Lind, CM Lindgren, S Lubitz, T Palmer… - Nature …, 2020 - nature.com
Circulating proteins are vital in human health and disease and are frequently used as
biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we …

Are patents and copyrights morally justified-the philosophy of property rights and ideal objects

TG Palmer - Harv. JL & Pub. Pol'y, 1990 - HeinOnline
Arguments for the right of property ownership are manifold. It is quite common for a single
author to invoke a wide range of these arguments to support private property rights, as in John …

Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization …

CE Dale, G Fatemifar, TM Palmer, J White… - Circulation, 2017 - Am Heart Assoc
Background: The implications of different adiposity measures on cardiovascular disease
etiology remain unclear. In this article, we quantify and contrast causal associations of central …

[HTML][HTML] Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England …

M Shrotri, M Krutikov, T Palmer, R Giddings… - The Lancet Infectious …, 2021 - thelancet.com
Background The effectiveness of SARS-CoV-2 vaccines in older adults living in long-term
care facilities is uncertain. We investigated the protective effect of the first dose of the Oxford-…